Medprin Regenerative Medical Technologies Co.,Ltd.’s Net Profit Dropped 43.6% in First Half of 2023

Medprin Regenerative Medical Technologies Co.,Ltd. (广州迈普再生医学科技股份有限公司) (301033.SZ) reported a net profit of 11.9 million yuan in the first half of 2023, down 43.6% year-on-year.

Meanwhile, the company posted 85.7 million yuan in revenue, down 9.8% year-on-year.

At the end of the reporting period, it had 720.2 million yuan in total assets and 118.9 million yuan in total liabilities, with a liability-to-asset ratio of 16.5%.